4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001636178-26-000009
CFO AND TREASURER sold 10,000 shares at an average $574.88 ($5,748,802)
- CFO AND TREASURER acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
EDGEMOND JAMES · CFO AND TREASURER
Table I: Non-derivative
12 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-13 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,000 | $135.42 | $1,354,200 | 28,876 | D |
| 2026-04-13 | Sale : show line 2 in the form 10b5-1 | −40 | $569.61 | $22,784 | 28,836 | D |
| 2026-04-13 | Sale : show line 3 in the form 10b5-1 | −281 | $571.14 | $160,490 | 28,555 | D |
| 2026-04-13 | Sale : show line 4 in the form 10b5-1 | −1,154 | $571.76 | $659,814 | 27,401 | D |
| 2026-04-13 | Sale : show line 5 in the form 10b5-1 | −1,210 | $572.96 | $693,279 | 26,191 | D |
| 2026-04-13 | Sale : show line 6 in the form 10b5-1 | −1,860 | $574.00 | $1,067,636 | 24,331 | D |
| 2026-04-13 | Sale : show line 7 in the form 10b5-1 | −1,457 | $575.06 | $837,856 | 22,874 | D |
| 2026-04-13 | Sale : show line 8 in the form 10b5-1 | −1,354 | $575.96 | $779,844 | 21,520 | D |
| Open-market sales · 10,000 sh · avg $574.88 · $5,748,802 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-13 | Exercise or conversion : show line 13 in the form 10b5-1 Stock Option | −10,000 | 92,500 | D |
Loading xslF345X06/primarydocument.xml…